{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T18:33:49Z","timestamp":1795026829947,"version":"4.10.2"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T00:00:00Z","timestamp":1756771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T00:00:00Z","timestamp":1756771200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2025,11,30]]},"DOI":"10.1038\/s41416-025-03144-9","type":"journal-article","created":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T17:13:49Z","timestamp":1756833229000},"page":"1565-1582","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Lipidomic profiling of human bile distinguishes cholangiocarcinoma from benign bile duct diseases with high specificity and sensitivity: a prospective descriptive study"],"prefix":"10.1038","volume":"133","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1175-5209","authenticated-orcid":false,"given":"Fu-Sheng","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Yi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-Kun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-Yu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Hua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-mian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-He","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Yu","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Bo","family":"Chai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Xian","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu-Yun","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian-Gen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Jie","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Hua","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song-Mei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3924-3803","authenticated-orcid":false,"given":"Yu-Feng","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,2]]},"reference":[{"key":"3144_CR1","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrgastro.2016.51","volume":"13","author":"JM Banales","year":"2016","unstructured":"Banales JM, Cardinale V, Carpino G, Marzioni M, Andersen JB, Invernizzi P, et al. Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA). Nat Rev Gastroenterol Hepatol. 2016;13:261\u201380.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"3144_CR2","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/s41572-021-00300-2","volume":"7","author":"PJ Brindley","year":"2021","unstructured":"Brindley PJ, Bachini M, Ilyas SI, Khan SA, Loukas A, Sirica AE, et al. Cholangiocarcinoma. Nat Rev Dis Prim. 2021;7:65.","journal-title":"Nat Rev Dis Prim"},{"key":"3144_CR3","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/s41575-020-0310-z","volume":"17","author":"JM Banales","year":"2020","unstructured":"Banales JM, Marin JJG, Lamarca A, Rodrigues PM, Khan SA, Roberts LR, et al. Cholangiocarcinoma 2020: the next horizon in mechanisms and management. Nat Rev Gastroenterol Hepatol. 2020;17:557\u201388.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"3144_CR4","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1016\/j.jhep.2022.07.022","volume":"77","author":"M Vithayathil","year":"2022","unstructured":"Vithayathil M, Khan SA. Current epidemiology of cholangiocarcinoma in Western countries. J Hepatol. 2022;77:1690\u20138.","journal-title":"J Hepatol"},{"key":"3144_CR5","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0140-6736(21)00153-7","volume":"397","author":"JW Valle","year":"2021","unstructured":"Valle JW, Kelley RK, Nervi B, Oh D-Y, Zhu AX. Biliary tract cancer. Lancet. 2021;397:428\u201344.","journal-title":"Lancet"},{"key":"3144_CR6","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.jhep.2023.01.027","volume":"78","author":"M Cadamuro","year":"2023","unstructured":"Cadamuro M, Al-Taee A, Gonda TA. Advanced endoscopy meets molecular diagnosis of cholangiocarcinoma. J Hepatol. 2023;78:1063\u201372.","journal-title":"J Hepatol"},{"key":"3144_CR7","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/liv.14090","volume":"39","author":"RIR Macias","year":"2019","unstructured":"Macias RIR, Kornek M, Rodrigues PM, Paiva NA, Castro RE, Urban S, et al. Diagnostic and prognostic biomarkers in cholangiocarcinoma. Liver Int. 2019;39:108\u201322.","journal-title":"Liver Int"},{"key":"3144_CR8","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.annonc.2022.10.506","volume":"34","author":"A Vogel","year":"2023","unstructured":"Vogel A, Bridgewater J, Edeline J, Kelley RK, Kl\u00fcmpen HJ, Malka D, et al. Biliary tract cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol. 2023;34:127\u201340.","journal-title":"Ann Oncol"},{"key":"3144_CR9","doi-asserted-by":"crossref","unstructured":"Navaneethan U, Hasan MK, Lourdusamy V, Njei B, Varadarajulu S, Hawes RH. Single-operator cholangioscopy and targeted biopsies in the diagnosis of indeterminate biliary strictures: a systematic review. Gastrointest Endosc 2015;82:608\u201314","DOI":"10.1016\/j.gie.2015.04.030"},{"key":"3144_CR10","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1021\/acsbiomaterials.3c00935","volume":"10","author":"I Khamaysi","year":"2024","unstructured":"Khamaysi I, Firman R, Martin P, Vasilyev G, Boyko E, Zussman E. Mechanical perspective on increasing brush cytology yield. ACS Biomater Sci Eng. 2024;10:1743\u201352.","journal-title":"ACS Biomater Sci Eng"},{"key":"3144_CR11","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1055\/a-2041-7687","volume":"55","author":"D Karsenti","year":"2023","unstructured":"Karsenti D, Privat J, Charissoux A, Perrot B, Leblanc S, Chaput U, et al. Multicenter randomized trial comparing diagnostic sensitivity and cellular abundance with aggressive versus standard biliary brushing for bile duct stenosis without mass syndrome. Endoscopy. 2023;55:796\u2013803.","journal-title":"Endoscopy"},{"key":"3144_CR12","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.gie.2014.09.017","volume":"81","author":"U Navaneethan","year":"2015","unstructured":"Navaneethan U, Njei B, Lourdusamy V, Konjeti R, Vargo JJ, Parsi MA. Comparative effectiveness of biliary brush cytology and intraductal biopsy for detection of malignant biliary strictures: a systematic review and meta-analysis. Gastrointest Endosc. 2015;81:168\u201376.","journal-title":"Gastrointest Endosc"},{"key":"3144_CR13","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s13244-024-01675-y","volume":"15","author":"C Zhang","year":"2024","unstructured":"Zhang C, Li Y, Song M, Sun Z, Han X, Ren J, et al. False-negative factors of percutaneous transluminal clamp biopsy for suspected malignant biliary stricture: 194 cases analyzed from a single center. Insights Imaging. 2024;15:108.","journal-title":"Insights Imaging"},{"key":"3144_CR14","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.jhep.2021.12.010","volume":"76","author":"L Izquierdo-Sanchez","year":"2022","unstructured":"Izquierdo-Sanchez L, Lamarca A, La Casta A, Buettner S, Utpatel K, Kl\u00fcmpen H-J, et al. Cholangiocarcinoma landscape in Europe: Diagnostic, prognostic and therapeutic insights from the ENSCCA Registry. J Hepatol. 2022;76:1109\u201321.","journal-title":"J Hepatol"},{"key":"3144_CR15","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s13045-022-01351-y","volume":"15","author":"M Nikanjam","year":"2022","unstructured":"Nikanjam M, Kato S, Kurzrock R. Liquid biopsy: current technology and clinical applications. J Hematol Oncol. 2022;15:131.","journal-title":"J Hematol Oncol"},{"key":"3144_CR16","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.semcancer.2022.03.013","volume":"84","author":"A Markou","year":"2022","unstructured":"Markou A, Tzanikou E, Lianidou E. The potential of liquid biopsy in the management of cancer patients. Semin Cancer Biol. 2022;84:69\u201379.","journal-title":"Semin Cancer Biol"},{"key":"3144_CR17","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/s41571-022-00660-y","volume":"19","author":"A Tivey","year":"2022","unstructured":"Tivey A, Church M, Rothwell D, Dive C, Cook N. Circulating tumour DNA - looking beyond the blood. Nat Rev Clin Oncol. 2022;19:600\u201312.","journal-title":"Nat Rev Clin Oncol"},{"key":"3144_CR18","doi-asserted-by":"crossref","first-page":"7872","DOI":"10.7150\/thno.44634","volume":"10","author":"CK Chen","year":"2020","unstructured":"Chen CK, Liao J, Li MS, Khoo BL. Urine biopsy technologies: Cancer and beyond. Theranostics. 2020;10:7872\u201388.","journal-title":"Theranostics"},{"key":"3144_CR19","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1111\/cas.16097","volume":"115","author":"Y Bao","year":"2024","unstructured":"Bao Y, Zhang D, Guo H, Ma W. Beyond blood: Advancing the frontiers of liquid biopsy in oncology and personalized medicine. Cancer Sci. 2024;115:1060\u201372.","journal-title":"Cancer Sci"},{"key":"3144_CR20","volume":"55","author":"S He","year":"2023","unstructured":"He S, Zeng F, Yin H, Wang P, Bai Y, Song Q, et al. Molecular diagnosis of pancreatobiliary tract cancer by detecting mutations and methylation changes in bile samples. EClinicalMedicine. 2023;55:101736.","journal-title":"EClinicalMedicine"},{"key":"3144_CR21","volume":"23","author":"J Wu","year":"2024","unstructured":"Wu J, Lin Y, Yang K, Liu X, Wang H, Yu T, et al. Clinical effectiveness of a multitarget urine DNA test for urothelial carcinoma detection: a double-blinded, multicenter, prospective trial. Mol Cancer. 2024;23:57.","journal-title":"Mol Cancer"},{"key":"3144_CR22","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1136\/gutjnl-2021-325178","volume":"71","author":"M Arechederra","year":"2022","unstructured":"Arechederra M, Rull\u00e1n M, Amat I, Oyon D, Zabalza L, Elizalde M, et al. Next-generation sequencing of bile cell-free DNA for the early detection of patients with malignant biliary strictures. Gut. 2022;71:1141\u201351.","journal-title":"Gut"},{"key":"3144_CR23","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/hep.32125","volume":"75","author":"HM Vedeld","year":"2021","unstructured":"Vedeld HM, Grimsrud MM, Andresen K, Pharo HD, von Seth E, Karlsen TH, et al. Early and accurate detection of cholangiocarcinoma in patients with primary sclerosing cholangitis by methylation markers in bile. Hepatology. 2021;75:59\u201373.","journal-title":"Hepatology"},{"key":"3144_CR24","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1002\/hep.32496","volume":"76","author":"N Sharma","year":"2022","unstructured":"Sharma N, Yadav M, Tripathi G, Mathew B, Bindal V, Falari S, et al. Bile multi\u2010omics analysis classifies lipid species and microbial peptides predictive of carcinoma of the gallbladder. Hepatology. 2022;76:920\u201335.","journal-title":"Hepatology"},{"key":"3144_CR25","doi-asserted-by":"crossref","unstructured":"Yang S, Fu J, Qin W, Wang R, Gu M, Huang Y, et al. Bile metabolic fingerprints distinguish biliary tract cancer from benign biliary diseases. Hepatology. 2025;81:476\u201391","DOI":"10.1097\/HEP.0000000000000957"},{"key":"3144_CR26","doi-asserted-by":"crossref","unstructured":"Jin H-R, Wang J, Wang Z-J, Xi M-J, Xia B-H, Deng K, et al. Lipid metabolic reprogramming in tumor microenvironment: from mechanisms to therapeutics. J Hematol Oncol 2023;16:103","DOI":"10.1186\/s13045-023-01498-2"},{"key":"3144_CR27","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/s42255-023-00786-y","volume":"5","author":"YG Jeon","year":"2023","unstructured":"Jeon YG, Kim YY, Lee G, Kim JB. Physiological and pathological roles of lipogenesis. Nat Metab. 2023;5:735\u201359.","journal-title":"Nat Metab"},{"key":"3144_CR28","volume":"14","author":"G Wang","year":"2022","unstructured":"Wang G, Qiu M, Xing X, Zhou J, Yao H, Li M, et al. Lung cancer scRNA-seq and lipidomics reveal aberrant lipid metabolism for early-stage diagnosis. Sci Transl Med. 2022;14:eabk2756.","journal-title":"Sci Transl Med"},{"key":"3144_CR29","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-27765-9","volume":"13","author":"D Wolrab","year":"2022","unstructured":"Wolrab D, Jir\u00e1sko R, C\u00edfkov\u00e1 E, H\u00f6ring M, Mei D, Chocholou\u0161kov\u00e1 M, et al. Lipidomic profiling of human serum enables detection of pancreatic cancer. Nat Commun. 2022;13:124.","journal-title":"Nat Commun"},{"key":"3144_CR30","doi-asserted-by":"crossref","unstructured":"Ecker J, Benedetti E, Kindt ASD, H\u00f6ring M, Perl M, Machm\u00fcller AC, et al. The colorectal cancer lipidome: identification of a robust tumor-specific lipid species signature. Gastroenterology 2021;161:910\u201323","DOI":"10.1053\/j.gastro.2021.05.009"},{"key":"3144_CR31","doi-asserted-by":"crossref","first-page":"4671","DOI":"10.7150\/thno.74770","volume":"12","author":"Z-C Liu","year":"2022","unstructured":"Liu Z-C, Wu W-H, Huang S, Li Z-W, Li X, Shui G-H, et al. Plasma lipids signify the progression of precancerous gastric lesions to gastric cancer: a prospective targeted lipidomics study. Theranostics. 2022;12:4671\u201383.","journal-title":"Theranostics"},{"key":"3144_CR32","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1002\/ijc.33943","volume":"150","author":"X Yan","year":"2022","unstructured":"Yan X, Zhao W, Wei J, Yao Y, Sun G, Wang L, et al. A serum lipidomics study for the identification of specific biomarkers for endometrial polyps to distinguish them from endometrial cancer or hyperplasia. Int J Cancer. 2022;150:1549\u201359.","journal-title":"Int J Cancer"},{"key":"3144_CR33","volume":"554","author":"FS Liu","year":"2024","unstructured":"Liu FS, Liu YY, Hao XY, Liu B, Yan XY, Li AL, et al. Altered bile metabolome and its diagnostic potential for biliopancreatic malignancies. Clin Chim Acta. 2024;554:117777.","journal-title":"Clin Chim Acta"},{"key":"3144_CR34","doi-asserted-by":"crossref","first-page":"694","DOI":"10.6004\/jnccn.2023.0035","volume":"21","author":"AB Benson","year":"2023","unstructured":"Benson AB, D\u2019Angelica MI, Abrams T, Abbott DE, Ahmed A, Anaya DA, et al. NCCN Guidelines\u00ae Insights: Biliary Tract Cancers, Version 2.2023. J Natl Compr Canc Netw. 2023;21:694\u2013704.","journal-title":"J Natl Compr Canc Netw"},{"key":"3144_CR35","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/j.jhep.2023.07.013","volume":"79","author":"L T\u00e9llez","year":"2023","unstructured":"T\u00e9llez L, Payanc\u00e9 A, Tjwa E, Del Cerro MJ, Idorn L, Ovroutski S, et al. EASL-ERN position paper on liver involvement in patients with Fontan-type circulation. J Hepatol. 2023;79:1270\u2013301.","journal-title":"J Hepatol"},{"key":"3144_CR36","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1245\/s10434-017-6025-x","volume":"25","author":"YS Chun","year":"2018","unstructured":"Chun YS, Pawlik TM, Vauthey J-N. 8th Edition of the AJCC Cancer Staging Manual: Pancreas and hepatobiliary cancers. Ann Surg Oncol. 2018;25:845\u20137.","journal-title":"Ann Surg Oncol"},{"key":"3144_CR37","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jprot.2017.11.001","volume":"178","author":"M Audano","year":"2018","unstructured":"Audano M, Maldini M, De Fabiani E, Mitro N, Caruso D. Gender-related metabolomics and lipidomics: From experimental animal models to clinical evidence. J Proteom. 2018;178:82\u201391.","journal-title":"J Proteom"},{"key":"3144_CR38","doi-asserted-by":"crossref","unstructured":"Tabassum R, Wid\u00e9n E, Ripatti S. Effect of biological sex on human circulating lipidome: An overview of the literature. Atherosclerosis. 2023;384:117274","DOI":"10.1016\/j.atherosclerosis.2023.117274"},{"key":"3144_CR39","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1572-0241.2000.01685.x","volume":"95","author":"AH Patel","year":"2000","unstructured":"Patel AH, Harnois DM, Klee GG, LaRusso NF, Gores GJ. The utility of CA 19-9 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing cholangitis. Am J Gastroenterol. 2000;95:204\u20137.","journal-title":"Am J Gastroenterol"},{"key":"3144_CR40","doi-asserted-by":"crossref","unstructured":"Gou Q, Zhang CZ, Sun ZH, Wu LG, Chen Y, Mo ZQ, et al. Cell-free DNA from bile outperformed plasma as a potential alternative to tissue biopsy in biliary tract cancer. ESMO Open. 2021;6:100275","DOI":"10.1016\/j.esmoop.2021.100275"},{"key":"3144_CR41","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1002\/cncr.34717","volume":"129","author":"H Ohyama","year":"2023","unstructured":"Ohyama H, Hirotsu Y, Amemiya K, Miura Y, Hirose S, Oyama T, et al. Comparison of genomic profiling of circulating tumor DNA in pancreaticobiliary malignancies in plasma and bile. Cancer. 2023;129:1714\u201322.","journal-title":"Cancer"},{"key":"3144_CR42","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1136\/gutjnl-2016-312432","volume":"67","author":"J Mayerle","year":"2018","unstructured":"Mayerle J, Kalthoff H, Reszka R, Kamlage B, Peter E, Schniewind B, et al. Metabolic biomarker signature to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis. Gut. 2018;67:128\u201337.","journal-title":"Gut"},{"key":"3144_CR43","volume":"14","author":"Y Yao","year":"2023","unstructured":"Yao Y, Wang X, Guan J, Xie C, Zhang H, Yang J, et al. Metabolomic differentiation of benign vs malignant pulmonary nodules with high specificity via high-resolution mass spectrometry analysis of patient sera. Nat Commun. 2023;14:2339.","journal-title":"Nat Commun"},{"key":"3144_CR44","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/JS9.0000000000000006","volume":"109","author":"ZX Liu","year":"2023","unstructured":"Liu ZX, Wang L, Gao SG, Xue Q, Tan FW, Li ZL, et al. Plasma metabolomics study in screening and differential diagnosis of multiple primary lung cancer. Int J Surg. 2023;109:297\u2013312.","journal-title":"Int J Surg"},{"key":"3144_CR45","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41581-023-00781-2","volume":"20","author":"F Mauvais-Jarvis","year":"2023","unstructured":"Mauvais-Jarvis F. Sex differences in energy metabolism: natural selection, mechanisms and consequences. Nat Rev Nephrol. 2023;20:56\u201369.","journal-title":"Nat Rev Nephrol"},{"key":"3144_CR46","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1002\/bjs.11257","volume":"106","author":"S Otsuka","year":"2019","unstructured":"Otsuka S, Ebata T, Yokoyama Y, Igami T, Mizuno T, Yamaguchi J, et al. Benign hilar bile duct strictures resected as perihilar cholangiocarcinoma. Br J Surg. 2019;106:1504\u201311.","journal-title":"Br J Surg"},{"key":"3144_CR47","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1007\/s00330-021-08301-1","volume":"32","author":"TY Jeon","year":"2022","unstructured":"Jeon TY, Choi MH, Yoon SB, Soh JS, Moon S-H. Systematic review and meta-analysis of percutaneous transluminal forceps biopsy for diagnosing malignant biliary strictures. Eur Radio. 2022;32:1747\u201356.","journal-title":"Eur Radio"},{"key":"3144_CR48","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/cncy.22565","volume":"130","author":"D Giovannini","year":"2022","unstructured":"Giovannini D, Bailly A, Seigneurin A, Fior-Gozlan M, Eyraud P-Y, Roth G, et al. Biliary cytology: A diagnostic tree for adenocarcinoma based on a cohort of 135 patients with endoscopic retrograde cholangiopancreatography for stenosis of the extrahepatic bile duct. Cancer Cytopathol. 2022;130:433\u201342.","journal-title":"Cancer Cytopathol"},{"key":"3144_CR49","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1055\/a-1127-3265","volume":"52","author":"SW Ko","year":"2020","unstructured":"Ko SW, Lee SS, So H, Hwang JS, Song TJ, Lee SK, et al. A novel method of biopsy for indeterminate pancreaticobiliary strictures: tube-assisted biopsy. Endoscopy. 2020;52:589\u201394.","journal-title":"Endoscopy"},{"key":"3144_CR50","volume":"12","author":"Q Zhang","year":"2021","unstructured":"Zhang Q, Yao D, Rao B, Jian L, Chen Y, Hu K, et al. The structural basis for the phospholipid remodeling by lysophosphatidylcholine acyltransferase 3. Nat Commun. 2021;12:6869.","journal-title":"Nat Commun"},{"key":"3144_CR51","volume":"247","author":"P Liu","year":"2020","unstructured":"Liu P, Zhu W, Chen C, Yan B, Zhu L, Chen X, et al. The mechanisms of lysophosphatidylcholine in the development of diseases. Life Sci. 2020;247:117443.","journal-title":"Life Sci"},{"key":"3144_CR52","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-023-04801-4","volume":"21","author":"V Caponigro","year":"2023","unstructured":"Caponigro V, Tornesello AL, Merciai F, La Gioia D, Salviati E, Basilicata MG, et al. Integrated plasma metabolomics and lipidomics profiling highlights distinctive signature of hepatocellular carcinoma in HCV patients. J Transl Med. 2023;21:918.","journal-title":"J Transl Med"},{"key":"3144_CR53","volume":"13","author":"L Zhang","year":"2023","unstructured":"Zhang L, Liu X, Liu Y, Yan F, Zeng Y, Song Y, et al. Lysophosphatidylcholine inhibits lung cancer cell proliferation by regulating fatty acid metabolism enzyme long-chain acyl-coenzyme A synthase 5. Clin Transl Med. 2023;13:e1180.","journal-title":"Clin Transl Med"}],"updated-by":[{"DOI":"10.1038\/s41416-025-03237-5","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000}}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-03144-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-03144-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-03144-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T18:14:46Z","timestamp":1762884886000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-03144-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,2]]},"references-count":53,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,11,30]]}},"alternative-id":["3144"],"URL":"https:\/\/doi.org\/10.1038\/s41416-025-03144-9","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,2]]},"assertion":[{"value":"1 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2025","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised: In the Conclusions section, the article originally read: \u201cThis study not only identified lipidomic alterations in CCA using bile samples but also established and validated a sex-related bile lipid classifier with high specificity and sensitivity for distinguishing between CCA and benign bile duct diseases.\u201d The correct sentence is as follows (\u201csex-related\u201d removed): \u201cThis study not only identified lipidomic alterations in CCA using bile samples but also established and validated a bile lipid classifier with high specificity and sensitivity for distinguishing between CCA and benign bile duct diseases.\u201d","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2025","order":9,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":10,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41416-025-03237-5","URL":"https:\/\/doi.org\/10.1038\/s41416-025-03237-5","order":12,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was approved by the Medical Ethics Committee of the Clinical Trial Centre at Zhongnan Hospital, Wuhan University (Approval number: Scientific Research Ethics[2020100]). Informed consent for sample collection was obtained from all patients, and the study procedures followed the Declaration of Helsinki Guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All the authors agree to the publication of the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}